Provided by Tiger Trade Technology Pte. Ltd.

Rezolute, Inc.

4.62
-0.3600-7.23%
Post-market: 4.650.0300+0.65%19:49 EDT
Volume:1.08M
Turnover:5.07M
Market Cap:444.87M
PE:-5.75
High:4.95
Open:4.95
Low:4.58
Close:4.98
52wk High:11.46
52wk Low:1.07
Shares:96.29M
Float Shares:72.51M
Volume Ratio:0.46
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8039
EPS(LYR):-0.9791
ROE:-81.73%
ROA:-48.74%
PB:3.81
PE(LYR):-4.72

Loading ...

Rezolute Says Cash Position Totals $120 Million, Funds Operations into Mid-2028

Reuters
·
Aug 26

Rezolute Shares to Show Strength Towards Upcoming Ersodetug Catalysts, Wedbush Says

MT Newswires Live
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Boston Scientific (BSX)

TIPRANKS
·
Jul 30

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
Jul 14

Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar

Simply Wall St.
·
Jul 12

Rezolute Posts Corporate Deck on Phase 3 Ersodetug Program for Refractory Hypoglycemia in Hyperinsulinism

Reuters
·
Jun 27

Rezolute highlights Phase 3 sunRIZE data for ersodetug in congenital hyperinsulinism at ENDO meeting

Reuters
·
Jun 17

Rezolute Is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 15

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Vericel (VCEL)

TIPRANKS
·
Jun 10

Craig-Hallum Keeps Their Hold Rating on Rezolute (RZLT)

TIPRANKS
·
Jun 05

Rezolute flags Phase 3 sunRIZE top-line results for ersodetug in congenital hyperinsulinism at ENDO 2026

Reuters
·
Jun 04

Rezolute Raised to Market Outperform From Market Perform by Citizens

Dow Jones
·
Jun 03

Wedbush Adjusts Price Target on Rezolute to $6 From $5, Maintains Outperform Rating

MT Newswires Live
·
Jun 03

Rezolute Is Maintained at Buy by BTIG

Dow Jones
·
Jun 03

Rezolute upgraded to Outperform from Market Perform at Citizens

TIPRANKS
·
Jun 03

Rezolute price target raised to $6 from $5 at BTIG

TIPRANKS
·
Jun 03

Analysts Are Bullish on These Healthcare Stocks: Rezolute (RZLT), Relay Therapeutics (RLAY)

TIPRANKS
·
Jun 03

Rezolute price target raised to $14 from $10 at Maxim

TIPRANKS
·
Jun 03

Rezolute Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 02

BUZZ-U.S. STOCKS ON THE MOVE-Dollar General, Vera, Amtech Systems

Reuters
·
Jun 02